1. Alirocumab decreases plasma Lp(a) levels without enhancing Lp(a) liver uptake in vivo. (August 2018) Authors: Beeske, S.; Poirier, B.; Villard, E.F.; Le Bail, J.C.; Dargazanli, G.; Tran, T.T.T.; Ho-Van Guimbal, S.; Bayard, A.; Tirode, F.; Boulay, D.; Bergis, O.; Lambert, G.; Pruniaux, M.P.; Janiak, P.; Guillot, E. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An ion‐pairing, reversed‐phase liquid chromatography method to assess the cross‐contamination of cancer chemotherapy infusions prepared in a dual‐operator aseptic isolator. Issue 9 (20th October 2015) Authors: Brachet, G.; Bruno, C.; Boulay, D.; Tournamille, J. F.; Gyan, E.; Viaud‐Massuard, M. C.; Respaud, R. Journal: Drug testing and analysis Issue: Volume 8:Issue 9(2016:Sep.) Page Start: 985 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗